Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms

This article is cited by 31 publications.

1. Tao Yang, Mengshi Hu, Yong Chen, Mingli Xiang, Minghai Tang, Wenyan Qi, Mingsong Shi, Jun He, Xue Yuan, Chufeng Zhang, Kongjun Liu, Jiewen Li, Zhuang Yang, Lijuan Chen. N-(Pyrimidin-2-yl)-1,2,3,4-tetrahydroisoquinolin-6-amine Derivatives as Selective Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms. Journal of Medicinal Chemistry 2020, 63 (23) , 14921-14936. https://doi.org/10.1021/acs.jmedchem.0c01488
2. Neil A. Strotman, Maxime C. Soumeillant, Keming Zhu, Chester E. Markwalter, Carolyn S. Wei, Yi Hsiao, Martin D. Eastgate. Effects of Multiple Catalyst Deactivation Pathways and Continuous Ligand Recycling on the Kinetics of Pd-Catalyzed C–N Coupling Reactions. The Journal of Organic Chemistry 2019, 84 (8) , 4653-4660. https://doi.org/10.1021/acs.joc.8b02214
3. Marian C. Bryan, Naomi S. Rajapaksa. Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances. Journal of Medicinal Chemistry 2018, 61 (20) , 9030-9058. https://doi.org/10.1021/acs.jmedchem.8b00667
4. Amy C. Hart, Gretchen M. Schroeder, Honghe Wan, James Grebinski, Jennifer Inghrim, James Kempson, Junqing Guo, William J. Pitts, John S. Tokarski, John S. Sack, Javed A. Khan, Jonathan Lippy, Matthew V. Lorenzi, Dan You, Theresa McDevitt, Ragini Vuppugalla, Yueping Zhang, Louis J. Lombardo, George L. Trainor, and Ashok V. Purandare . Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine Inhibitors. ACS Medicinal Chemistry Letters 2015, 6 (8) , 845-849. https://doi.org/10.1021/acsmedchemlett.5b00225
5. Min-Yan Zhao, Wen Zhang, Guo-Wu Rao. Targeting Janus Kinase (JAK) for Fighting Diseases: The Research of JAK Inhibitor Drugs. Current Medicinal Chemistry 2022, 29 (29) , 5010-5040. https://doi.org/10.2174/1568026622666220307124142
6. Dandan Liu, Huan Ge, Fangling Xu, Yufang Xu, Wenjun Liu, Honglin Li, Lili Zhu, Yanyan Diao, Zhenjiang Zhao. Design, synthesis and SAR study of 2-aminopyridine derivatives as potent and selective JAK2 inhibitors. Chinese Chemical Letters 2022, 33 (6) , 2969-2974. https://doi.org/10.1016/j.cclet.2021.12.099
7. Mohammed I. El-Gamal, Seyed-Omar Zaraei, Moustafa M. Madkour, Hanan S. Anbar. Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011–2020): Current Status and Future Prospects. Molecules 2022, 27 (1) , 330. https://doi.org/10.3390/molecules27010330
8. Gregory A. Locke, Jodi Muckelbauer, John S. Tokarski, Christopher M. Barbieri, Stefan Belić, Bradley Falk, Jeffrey Tredup, Ying-Kai Wang. Identification and characterization of TYK2 pseudokinase domain stabilizers that allosterically inhibit TYK2 signaling. 2022, 685-727. https://doi.org/10.1016/bs.mie.2022.03.051
9. Paul Beinhoff, Lavannya Sabharwal, Vindhya Udhane, Cristina Maranto, Peter S. LaViolette, Kenneth M. Jacobsohn, Susan Tsai, Kenneth A. Iczkowski, Liang Wang, William A. Hall, Scott M. Dehm, Deepak Kilari, Marja T. Nevalainen. Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?. Cancers 2021, 13 (20) , 5204. https://doi.org/10.3390/cancers13205204
10. Cinzia Bordoni, Daniel J. Brough, Gemma Davison, James H. Hunter, J. Daniel Lopez-Fernandez, Kate McAdam, Duncan C. Miller, Pasquale A. Morese, Alexia Papaioannou, Mélanie Uguen, Paul Ratcliffe, Nikolay Sitnikov, Michael J. Waring. Cardiac Ion Channel Inhibition. 2021, 403-492. https://doi.org/10.1039/9781788016414-00403
11. Pengfei Xu, Pei Shen, Hai Wang, Lian Qin, Jie Ren, Qiushuang Sun, Raoling Ge, Jinlei Bian, Yi Zhong, Zhiyu Li, JuBo Wang, Zhixia Qiu. Discovery of imidazopyrrolopyridines derivatives as novel and selective inhibitors of JAK2. European Journal of Medicinal Chemistry 2021, 218 , 113394. https://doi.org/10.1016/j.ejmech.2021.113394
12. Kamonpan Sanachai, Thitinan Aiebchun, Panupong Mahalapbutr, Supaphorn Seetaha, Lueacha Tabtimmai, Phornphimon Maitarad, Iakovos Xenikakis, Athina Geronikaki, Kiattawee Choowongkomon, Thanyada Rungrotmongkol. Discovery of novel JAK2 and EGFR inhibitors from a series of thiazole-based chalcone derivatives. RSC Medicinal Chemistry 2021, 12 (3) , 430-438. https://doi.org/10.1039/D0MD00436G
13. Seketoulie Keretsu, Swapnil Pandurang Bhujbal, Seung Joo Cho. Computational Study of Pyrimidin‐2‐Aminopyrazol‐Hydroxamate‐based JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms. Bulletin of the Korean Chemical Society 2020, 41 (5) , 542-551. https://doi.org/10.1002/bkcs.12008
14. Pengfei Xu, Pei Shen, Bin Yu, Xi Xu, Raoling Ge, Xinying Cheng, Qiuyu Chen, Jinlei Bian, Zhiyu Li, JuBo Wang. Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders. European Journal of Medicinal Chemistry 2020, 192 , 112155. https://doi.org/10.1016/j.ejmech.2020.112155
15. Fatima Ezzahra Bennani, Latifa Doudach, Yahia Cherrah, Youssef Ramli, Khalid Karrouchi, M'hammed Ansar, My El Abbes Faouzi. Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line. Bioorganic Chemistry 2020, 97 , 103470. https://doi.org/10.1016/j.bioorg.2019.103470
16. Xiangyu Ma, Yanyan Diao, Huan Ge, Fangling Xu, Lili Zhu, Zhenjiang Zhao, Honglin Li. Discovery and optimization of 2-aminopyridine derivatives as novel and selective JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters 2020, 30 (8) , 127048. https://doi.org/10.1016/j.bmcl.2020.127048
17. Maja Kim Kuepper, Marlena Bütow, Oliver Herrmann, Janine Ziemons, Nicolas Chatain, Angela Maurer, Martin Kirschner, Tiago Maié, Ivan G. Costa, Jörg Eschweiler, Steffen Koschmieder, Tim H. Brümmendorf, Gerhard Müller-Newen, Mirle Schemionek. Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling. Leukemia 2019, 33 (8) , 1964-1977. https://doi.org/10.1038/s41375-019-0427-7
18. Francesca Musumeci, Chiara Greco, Ilaria Giacchello, Anna Lucia Fallacara, Munjed M. Ibrahim, Giancarlo Grossi, Chiara Brullo, Silvia Schenone. An Update on JAK Inhibitors. Current Medicinal Chemistry 2019, 26 (10) , 1806-1832. https://doi.org/10.2174/0929867325666180327093502
19. Nancy Abdelgawad, Mahmoud F. Ismail, Mohamed H. Hekal, Magda I. Marzouk. Design, Synthesis, and Evaluation of Some Novel Heterocycles Bearing Pyrazole Moiety as Potential Anticancer Agents. Journal of Heterocyclic Chemistry 2019, 56 (6) , 1771-1779. https://doi.org/10.1002/jhet.3544
20. Mark Zak, Emily J. Hanan, Patrick Lupardus, David G. Brown, Colin Robinson, Michael Siu, Joseph P. Lyssikatos, F. Anthony Romero, Guiling Zhao, Terry Kellar, Rohan Mendonca, Nicholas C. Ray, Simon C. Goodacre, Peter H. Crackett, Neville McLean, Christopher A. Hurley, Po-wai Yuen, Yun-Xing Cheng, Xiongcai Liu, Marya Liimatta, Pawan Bir Kohli, Jim Nonomiya, Gary Salmon, Gerry Buckley, Julia Lloyd, Paul Gibbons, Nico Ghilardi, Jane R. Kenny, Adam Johnson. Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling. Bioorganic & Medicinal Chemistry Letters 2019, 29 (12) , 1522-1531. https://doi.org/10.1016/j.bmcl.2019.04.008
21. Ning Ding, Sam A. Miller, Sudha S. Savant, Heather M. O'Hagan. JAK2 regulates mismatch repair protein‐mediated epigenetic alterations in response to oxidative damage. Environmental and Molecular Mutagenesis 2019, 60 (4) , 308-319. https://doi.org/10.1002/em.22269
22. Julia Czech, Sabrina Cordua, Barbora Weinbergerova, Julian Baumeister, Assja Crepcia, Lijuan Han, Tiago Maié, Ivan G. Costa, Bernd Denecke, Angela Maurer, Claudia Schubert, Kristina Feldberg, Deniz Gezer, Tim H. Brümmendorf, Gerhard Müller-Newen, Jiri Mayer, Zdenek Racil, Blanka Kubesova, Trine Knudsen, Anders L. Sørensen, Morten Holmström, Lasse Kjær, Vibe Skov, Thomas Stauffer Larsen, Hans C. Hasselbalch, Nicolas Chatain, Steffen Koschmieder. JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation. Leukemia 2019, 33 (4) , 995-1010. https://doi.org/10.1038/s41375-018-0295-6
23. Hui Gao, Songqing Mei, Jing Zhao, Kangcheng Zheng, Siyan Liao. Study on the binding mode of a pyrrolotriazin derivative with JAK2 by docking and MD simulation. Molecular Simulation 2019, 45 (3) , 230-238. https://doi.org/10.1080/08927022.2018.1557330
24. Christopher M. Cimarusti, David R. Kronenthal. The Discovery/Development Transition. 2018, 31-48. https://doi.org/10.1002/9783527801756.ch3
25. Aladdin M. Srour, Hoda H. Fahmy, Mai A. Khater, May A. El-Manawaty, ElSayed M. Shalaby. Synthesis, characterization, and cytotoxic activity of some new 1,3,4-trisubstituted pyrazoles against diverse tumor cell lines. Monatshefte für Chemie - Chemical Monthly 2018, 149 (6) , 1137-1147. https://doi.org/10.1007/s00706-018-2153-7
26. Raquib Alam, Md. Aftab Alam, Amulya K. Panda, Rahisuddin. Design, Synthesis, and Cytotoxicity Evaluation of 3‐(5‐(3‐(aryl)‐1‐phenyl‐1H‐pyrazol‐4‐yl)‐1‐phenyl‐4,5‐dihydro‐1H‐pyrazol‐3‐yl)pyridine and 5‐(3‐(aryl)‐1‐phenyl‐1H‐pyrazol‐4‐yl)‐3‐(pyridin‐3‐yl)‐4,5‐dihydropyrazole‐1‐carbaldehyde Derivatives as Potential Anticancer Agents. Journal of Heterocyclic Chemistry 2017, 54 (3) , 1812-1821. https://doi.org/10.1002/jhet.2768
27. Yazhou Wang, Wei Huang, Minhang Xin, Pan Chen, Li Gui, Xinge Zhao, Feng Tang, Jia Wang, Fei Liu. Identification of 4-(2-furanyl)pyrimidin-2-amines as Janus kinase 2 inhibitors. Bioorganic & Medicinal Chemistry 2017, 25 (1) , 75-83. https://doi.org/10.1016/j.bmc.2016.10.011
28. Wenteng Chen, Xingyu Liu, En Chen, Binhui Chen, Jiaan Shao, Yongping Yu. KI-mediated radical multi-functionalization of vinyl azides: a one-pot and efficient approach to β-keto sulfones and α-halo-β-keto sulfones. Organic Chemistry Frontiers 2017, 4 (6) , 1162-1166. https://doi.org/10.1039/C6QO00756B
29. Ting-Ting Yao, Jiang-Feng Xie, Xing-Guo Liu, Jing-Li Cheng, Cheng-Yuan Zhu, Jin-Hao Zhao, Xiao-Wu Dong. Integration of pharmacophore mapping and molecular docking in sequential virtual screening: towards the discovery of novel JAK2 inhibitors. RSC Advances 2017, 7 (17) , 10353-10360. https://doi.org/10.1039/C6RA24959K
30. Raquib Alam, Divya Wahi, Raja Singh, Devapriya Sinha, Vibha Tandon, Abhinav Grover, Rahisuddin. Design, synthesis, cytotoxicity, HuTopoIIα inhibitory activity and molecular docking studies of pyrazole derivatives as potential anticancer agents. Bioorganic Chemistry 2016, 69 , 77-90. https://doi.org/10.1016/j.bioorg.2016.10.001
31. Siyu Wang, Rong Jin, Ruiquan Wang, Yongzhou Hu, Xiaowu Dong, Ai e Xu. The design, synthesis and biological evaluation of pro-EGCG derivatives as novel anti-vitiligo agents. RSC Advances 2016, 6 (108) , 106308-106315. https://doi.org/10.1039/C6RA23172A